More evidence why sex and gender matter: aspirin and metabolic syndrome

Levine RI , The puzzle of aspirin and sex. Editorial, NEJM Vol. 352: 1366–8, March 31, 2005 http://content.nejm.org/cgi/content/full/352/13/1366/.

Lahn B.T. , Page D.C. , et al. Four evolutionary strata on the human X chromosome. Science, 1999; 286:964–967. [Erratum, Science 1999;286:2273.] [Abstract/Full Text].

Ridker P.M. , Cook N.R. , Lee I.-M. , et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med, 2005; 352:1293–1304 [Abstract/Full Text].

Mendez M.A. , Monteiro C.A. , Popkin B.M. Overweight exceeds underweight among women in most developing countries. Am J Clin Nutr, 2005; 81:714–721.

Eisenmann J.C. , Wickel E.E. , Gregory M.S. , et al. Relationship Between Adolescent Fitness and Fatness and Cardiovascular Disease Risk Factors in Adulthood: The Aerobics Center Longitudinal Study (ACLS). Am Heart J, 2005; 149(1):46–53.

Goodpaster B.H. , Krishnaswami S. , Harris T. , et al. Obesity, Regional Body Fat Distribution, and the Metabolic Syndrome in Older Men and Women. Arch Intern Med, 2005; 165:777–783.

Snow V , Barry P , Fitterman N , et al. Pharmacologic and Surgical Management of Obesity in Primary Care: A Clinical Practice Guideline from the American College of Physicians. Ann Intern Med, 2005; 142(7):525–31.

Pagotto U. , Pasquali R. , et al. Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. Lancet, 2005; 365(9468):1363–1364.

Van Gaal L.F. , Rissanen A.M. , Scheen A.J. , et al. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet, 2005; 365:1389–1397.

Orchard TJ , Temprosa M , Goldberg R , et al. The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial. Ann Intern Med, 2005; 142(8):611–9.